PTEN and neoplasm: ,4,43,44 GEM models have generally supported this clinical relationship: Engineered reduction of PTEN causes enhanced tumor susceptibility and incidence,10,11 whereas PTEN overexpression augments its tumor-suppressive function and protects from tumorigenesis,12 strongly suggesting that PTEN levels are associated with tumor initiation and progression.8